Eswatini

5 Vaccines Approved for Use in Eswatini

RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: eswatinihealth.org
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: aa.com.tr
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Approval Source: afro.who.int
Protein Subunit

Medigen

MVC-COV1901

Approved in 4 countries
15 trials in 4 countries
Approval Source: metrotvnews.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Approval Source: aa.com.tr

1 in Clinical Trials in Eswatini

RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries